Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krister J Barkovich

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Small Science|March 11, 2024
iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer DeliveryKrister J Barkovich, Zhongchao Zhao, Nicole F Steinmetz
Nucleic Acids Research|August 14, 2018
Chemical genetic inhibition of DEAD-box proteins using covalent complementarityKrister J Barkovich, Megan K Moore, Qi Hu, et al.
Scientific Reports|December 12, 2025
Engineering filamentous potato virus X as a platform nanotechnology for nucleic acid gene deliveryBryan Duoto, Michael Tong, Krister J Barkovich, et al.
Bioconjugate Chemistry|August 24, 2023
Physalis Mottle Virus-Like Nanocarriers with Expanded Internal Loading CapacityKrister J Barkovich, Zhuohong Wu, Zhongchao Zhao, et al.
Protein Science : a Publication of the Protein Society|December 10, 2015
Analog sensitive chemical inhibition of the DEAD-box protein DDX3Stephen N Floor, Krister J Barkovich, Kendall J Condon, et al.
ACS Chemical Biology|September 22, 2018
Type II Kinase Inhibitors Targeting Cys-Gatekeeper Kinases Display Orthogonality with Wild Type and Ala/Gly-Gatekeeper KinasesCory A Ocasio, Alexander A Warkentin, Patrick J McIntyre, et al.
Abdominal Radiology (New York)|June 20, 2024
Contrast-enhanced ultrasound of renal masses in the pre-transplant setting: literature review with case highlightsKrister J Barkovich, Amanda C Gibson, Sneh Brahmbhatt, et al.
Nano Letters|January 31, 2024
Virus-like Particles Armored by an EndoskeletonZhuohong Wu, Jorge L Bayón, Tatiana B Kouznetsova, et al.
Cancer Discovery|May 17, 2012
Kinetics of inhibitor cycling underlie therapeutic disparities between EGFR-driven lung and brain cancersKrister J Barkovich, Sujatmi Hariono, Adam L Garske, et al.
Journal of Neuro-Oncology|November 17, 2016
Combined BRAF<sup>V600E</sup> and MEK blockade for BRAF<sup>V600E</sup>-mutant gliomasJie Zhang, Tsun-Wen Yao, Rintaro Hashizume, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Small Science|March 11, 2024
iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer DeliveryKrister J Barkovich, Zhongchao Zhao, Nicole F Steinmetz
Nucleic Acids Research|August 14, 2018
Chemical genetic inhibition of DEAD-box proteins using covalent complementarityKrister J Barkovich, Megan K Moore, Qi Hu, et al.
Scientific Reports|December 12, 2025
Engineering filamentous potato virus X as a platform nanotechnology for nucleic acid gene deliveryBryan Duoto, Michael Tong, Krister J Barkovich, et al.
Bioconjugate Chemistry|August 24, 2023
Physalis Mottle Virus-Like Nanocarriers with Expanded Internal Loading CapacityKrister J Barkovich, Zhuohong Wu, Zhongchao Zhao, et al.
Protein Science : a Publication of the Protein Society|December 10, 2015
Analog sensitive chemical inhibition of the DEAD-box protein DDX3Stephen N Floor, Krister J Barkovich, Kendall J Condon, et al.
ACS Chemical Biology|September 22, 2018
Type II Kinase Inhibitors Targeting Cys-Gatekeeper Kinases Display Orthogonality with Wild Type and Ala/Gly-Gatekeeper KinasesCory A Ocasio, Alexander A Warkentin, Patrick J McIntyre, et al.
Abdominal Radiology (New York)|June 20, 2024
Contrast-enhanced ultrasound of renal masses in the pre-transplant setting: literature review with case highlightsKrister J Barkovich, Amanda C Gibson, Sneh Brahmbhatt, et al.
Nano Letters|January 31, 2024
Virus-like Particles Armored by an EndoskeletonZhuohong Wu, Jorge L Bayón, Tatiana B Kouznetsova, et al.
Cancer Discovery|May 17, 2012
Kinetics of inhibitor cycling underlie therapeutic disparities between EGFR-driven lung and brain cancersKrister J Barkovich, Sujatmi Hariono, Adam L Garske, et al.
Journal of Neuro-Oncology|November 17, 2016
Combined BRAF<sup>V600E</sup> and MEK blockade for BRAF<sup>V600E</sup>-mutant gliomasJie Zhang, Tsun-Wen Yao, Rintaro Hashizume, et al.
Pageof 2